関連する実験動画
Updated: Jul 22, 2026

13:21
In Vivo Biosensor Tracks Non-apoptotic Caspase Activity in Drosophila
Published on: November 27, 2016
アダプタータンパク質Daxxによってアポトーシス信号調節キナーゼ1 (ASK1) の活性化
H Y Chang1, H Nishitoh, X Yang
1Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02138, USA.
まとめ
Fas死亡受容体の経路は,Daxxタンパク質を通じたJun NH2端子キナーゼ (JNK) 信号伝達を活性化させ,DAXXタンパク質はASK1キナーゼと相互作用して活性化させ,アポトーシスを促進する.
科学分野:
- 細胞の信号伝達経路は,
- アポトーシスと細胞死
- 分子生物学は分子生物学である.
背景:
- Fas死亡受容体は細胞アポトーシスを開始する.
- Daxxは,Fas受容体に関連したタンパク質です.
- Jun NH2端末キナーゼ (JNK) 経路の活性化は,アポトーシスにおいて極めて重要です.
研究 の 目的:
- ファス媒介のJNK活性化におけるDaxxの役割を明らかにする.
- Fas信号伝達経路におけるDaxxとASK1の相互作用を特定する.
- DaxxがASK1キナーゼ活性をどのように調節するかを理解するために.
主な方法:
- 野生型およびキナーゼ欠乏型ASK1変異体の過剰発現.
- ファスおよびダックス誘発のアポトーシスの分析.
- JNKのアクティベーションの評価.
- タンパク質の相互作用を研究するための共免疫プレシピテーション.
主要な成果:
- DaxxはJNKキナーゼキナーゼASK1.1.を活性化する.
- キナーゼ欠乏症ASK1変異体の過剰発現は,Fas-およびDaxx誘発のアポトーシスおよびJNK活性化を抑制する.
- Fasの活性化により,ASK1.1とのDaxx相互作用が促進される.
- ダックス結合はASK1の分子内抑制を緩和し,そのキナーゼ活性を活性化します.
結論:
- Daxx-ASK1の相互作用は,Fas誘発のJNK活性化とアポトーシスに不可欠である.
- この研究では,Fas受容体からJNK経路の活性化までのシグナリングカスケードが定義されています.
- この発見は,受容体関連タンパク質を通してASK1キナーゼの活性を調節するメカニズムを明らかにしています.
関連する概念動画
Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...

